Citation Impact
Citing Papers
Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization
1999 Standout
Computational Stabilization of a Non‐Heme Iron Enzyme Enables Efficient Evolution of New Function
2024 StandoutNobel
Functional diversity of helper T lymphocytes
1996 StandoutNature
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
2005 StandoutNobel
Improving the efficacy of antibody-based cancer therapies
2001
The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity
2011 StandoutNobel
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
The RNase a superfamily: Generation of diversity and innate host defense
2006
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Spinal-cord injury
2002 Standout
Ribonuclease P: An Enzyme with a Catalytic RNA Subunit
1989 StandoutNobel
Antibody engineering and modification technologies
2007
Apoptosis: controlled demolition at the cellular level
2007 Standout
Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon
1995
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
1992 StandoutNature
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
2001 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
The biology of VEGF and its receptors
2003 Standout
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
1994 Standout
The eight human “canonical” ribonucleases: Molecular diversity, catalytic properties, and special biological actions of the enzyme proteins
2010
Angiogenins: a new class of microbicidal proteins involved in innate immunity
2003
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Combinatorial infection andin vivorecombination: a strategy for making large phage antibody repertoires
1993 StandoutNobel
Circos: An information aesthetic for comparative genomics
2009 Standout
Modified Uridines with C5-methylene Substituents at the First Position of the tRNA Anticodon Stabilize U·G Wobble Pairing during Decoding
2008 StandoutNobel
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Building Antibodies from their Genes
1992 StandoutNobel
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
The Sygen® Multicenter Acute Spinal Cord Injury Study
2001
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
2006
Endoribonucleases – enzymes gaining spotlight in mRNA metabolism
2009
Selective cleavage of 28S rRNA variable regions V3 and V13 in myeloid leukemia cell apoptosis
1993
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
The Human Microbiome Project
2007 StandoutNature
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 Standout
Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism
2010
DNA‐Templated Organic Synthesis: Nature's Strategy for Controlling Chemical Reactivity Applied to Synthetic Molecules
2004 Standout
Eosinophils: Biology and Role in Disease
1995
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
1996 StandoutNature
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
1993 StandoutNature
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
1997 StandoutScience
A cytotoxic ribonuclease which specifically cleaves four isoaccepting arginine tRNAs at their anticodon loops
2000
A systems approach to cancer therapy
1996
Gut Microbiota in Health and Disease
2010 Standout
Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology
2005 Standout
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
1997 StandoutScience
Specific binding of angiogenin to calf pulmonary artery endothelial cells.
1989
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens
2001
Characterization in vitro of the defect in a temperature-sensitive mutant of the protein subunit of RNase P from Escherichia coli
1989 StandoutNobel
Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.
1994 StandoutNobel
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut
2004 StandoutNobel
Sequence specific cleavage of messenger RNA by a modified ribonuclease H
1994
Plant Products as Antimicrobial Agents
1999 Standout
"Diabodies": small bivalent and bispecific antibody fragments.
1993 StandoutNobel
Specific Interactions in RNA Enzyme-Substrate Complexes
1989 StandoutScienceNobel
Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis
1994
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Antibody–Enzyme Fusion Proteins for Cancer Therapy
2011
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1
1996 StandoutNobel
Directed evolution methods for overcoming trade‐offs between protein activity and stability
2019
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
Hodgkin's lymphoma
2003
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Angiogenin activates endothelial cell phospholipase C.
1988
Angiogenesis.
1992 Standout
Works of S.M. Rybak being referenced
Unique Recombinant Human Ribonuclease and Inhibition of Kaposi's Sarcoma Cell Growth
1998
Impact of antibody framework residue VH-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme
2004
Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment
2003
Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes.
1987
Expression and characterization of recombinant human eosinophil-derived neurotoxin and eosinophil-derived neurotoxin-anti-transferrin receptor sFv.
1994
Toxicity of an antitumor ribonuclease to Purkinje neurons
1994
Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily.
1992
Humanization of immunotoxins.
1992
Comparison of RNases and toxins upon injection into Xenopus oocytes.
1991
Gangliosides stimulate neurite outgrowth and induce tubulin mRNA accumulation in neural cells
1983
Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma.
2001
Cytotoxic potential of ribonuclease and ribonuclease hybrid proteins.
1991
Cytotoxic ribonuclease chimeras. Targeted tumoricidal activity in vitro and in vivo.
1992
IN-VITRO ANTITUMOR-ACTIVITY OF THE PLANT RIBOSOME-INACTIVATING PROTEINS MAP-30 AND GAP-31
1994